Anticoagulants are among the drugs most frequently linked to serious adverse events, and the standards for managing them are well documented. That makes anticoagulation cases attractive in one respect: the breach is often visible in the lab values, the dosing records, and the follow-up calendar. The more difficult work lies in proving causation and separating avoidable harm from the known risk of the drug.
The Risk Is Both Directions
Anticoagulation errors can cause bleeding when the drug effect is too high, or clotting events such as stroke and pulmonary embolism when the effect is too low or therapy is interrupted. Plaintiff counsel should look at the full course of care, not just the final event. A patient who suffered an intracranial hemorrhage with a markedly elevated INR may have had weeks of ignored abnormal values. A patient with a stroke after a procedure may have had anticoagulation stopped without a plan to restart or bridge.
Common Breaches
- Monitoring failures. Warfarin requires regular INR testing, with frequency depending on stability, dose changes, and new medications. Missed tests, delayed follow-up on abnormal results, and absence of a tracking system are common themes. Our medical malpractice coverage on lost test results discusses communication failures that often underlie these cases.
- Dosing and adjustment errors. Failure to adjust the dose after a supratherapeutic or subtherapeutic INR, adjusting by the wrong amount, or ignoring a trend.
- Drug and diet interactions. Antibiotics, antifungals, amiodarone, and many other drugs raise warfarin sensitivity. A prescriber or pharmacist who adds an interacting drug without alerting the anticoagulation clinic or increasing monitoring may be negligent.
- Inappropriate selection or dosing of newer agents. Direct oral anticoagulants require attention to renal function, age, weight, and interacting drugs. Wrong dosing in patients with kidney impairment is a recurring problem.
- Perioperative management. Holding anticoagulants before surgery, bridging with heparin when indicated, and restarting afterward require a plan. Errors include stopping too early or too late, failing to restart, or restarting without adjusting for bleeding risk.
- Failure to reverse. Delay in giving vitamin K, prothrombin complex concentrate, or specific reversal agents in a patient with life-threatening bleeding.
- Patient education. Inadequate instruction on bleeding signs, interactions, and the need for monitoring.
Where the Evidence Sits
Request the full anticoagulation record. That includes anticoagulation clinic notes, INR logs, point-of-care testing records, telephone encounters, and patient instructions. Pharmacy records identify new prescriptions and dispensing dates, and pharmacy interaction alerts show whether the system warned a pharmacist or prescriber and whether the alert was overridden. EMR audit trails can show when abnormal results were viewed, and by whom. Electronic prescribing records and medication reconciliation entries often reveal whether an interacting drug was added without notice to the anticoagulation provider.
For hospital care, obtain the medication administration record, order history, and any protocol for anticoagulation management. Many hospitals have pharmacist-led dosing protocols or computerized alerts, and failures to follow them are persuasive.
Guidelines and the Standard of Care
Professional societies publish guidelines on anticoagulation, including target INR ranges by indication, monitoring intervals, perioperative management, and reversal. They are evidence of the standard of care, though they do not themselves set it. Your expert should be able to explain the guideline, why it applied to this patient, and how the care departed from it. Same-specialty requirements may apply: for a primary care physician, an internist or family physician; for a hospital pharmacist, a pharmacist. Add a hematologist or neurologist to address the injury and causation.
Causation Challenges
Defense experts will argue that the bleed or clot would have happened despite proper management, that the event occurred while the INR was in range, or that the patient's comorbidities and noncompliance were responsible. Respond with a careful timeline of INR values against clinical events, showing the point at which the patient's risk rose and what intervention would have reduced it. In intracranial hemorrhage cases, radiology experts can address bleed size and timing. For stroke after interruption, a neurologist can address stroke mechanism and the relevant risk.
Noncompliance arguments are common. Look for documentation of what the patient was told, whether instructions were written, and whether the clinic followed up after missed appointments. A patient who missed tests because no one called to schedule them is not noncompliant in a meaningful sense.
Defendants and Apportionment
Anticoagulation care often involves multiple actors: a primary care physician, an anticoagulation clinic, a specialist who started the drug, a pharmacy, a surgeon, and a hospital. Identify who had responsibility at each point, including handoffs. Review state rules on apportionment and joint liability to decide on joinder. Wrongful death cases arising from fatal hemorrhage follow the usual structure, discussed in our wrongful death section.
Damages
Anticoagulant injuries are often severe: hemorrhagic stroke, spinal epidural hematoma with paralysis, gastrointestinal bleeding, and compartment syndrome. Life care planning is frequently significant. Where the plaintiff already had cardiac or vascular disease, expect life expectancy arguments, and prepare expert testimony on baseline function and what was lost.
Early Steps
- Create an INR and medication timeline before sending the file to an expert.
- Request pharmacy and EMR audit data in the first discovery set.
- Identify each provider's role in monitoring and handoffs.
- Confirm certificate of merit and same-specialty expert requirements in your state.
- Preserve evidence of what the patient was told and when.